Health
PharmAust delivers COVID-19 antiviral breakthrough – Business News
ASX-listed pharmaceutical company, PharmAust continues to kick goals in its endeavours to develop antiviral treatment and prevention therapeutics for COVID-19….
ASX-listed pharmaceutical company, PharmAust continues to kick goals in its endeavours to develop antiviral treatment and prevention therapeutics for COVID-19. The company has once again demonstrated that its lead drug candidates monepantel and monepantel sulfone appear to show protection against cell death in non-human primate systems. Human clinical trials are now on the cards with production of the drug suitable for human consumption having already commenced.
Last year the company revealed monepantel’s…
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News24 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General20 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General17 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank